BioVie Inc. Deferred Tax Assets, Goodwill and Intangible Assets
BioVie Inc. (BIVI) had Deferred Tax Assets, Goodwill and Intangible Assets of -$49.94 thousand as of 2025-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-08-13
- 2025-06-30: Deferred Tax Assets, Goodwill and Intangible Assets -$49.94K.
- 2024-06-30: Deferred Tax Assets, Goodwill and Intangible Assets -$114.16K.
- 2023-06-30: Deferred Tax Assets, Goodwill and Intangible Assets -$189.85K.
- 2022-06-30: Deferred Tax Assets, Goodwill and Intangible Assets -$258.21K.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets | Deferred Tax Assets, Goodwill and Intangible Assets as first filed |
|---|---|---|
| 2025-06-30 | -$49.94K 10-K · filed 2026-08-13 | |
| 2024-06-30 | -$114.16K S-1/A · filed 2026-08-06 | |
| 2023-06-30 | -$189.85K 10-K · filed 2024-09-30 | |
| 2022-06-30 | -$258.21K 10-K · filed 2023-08-16 | |
| 2021-06-30 | -$327.00K 10-K · filed 2022-09-27 | |
| 2020-06-30 | -$371.06K 10-K · filed 2021-08-30 | |
| 2019-06-30 | -$450.83K 10-K/A · filed 2020-08-07 | $36.92K 10-K · filed 2019-09-27 |
| 2018-06-30 | $19.28K 10-K · filed 2019-09-27 | |
| 2017-06-30 | $3.73K 10-K · filed 2018-10-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |